Vaccine countdown update: 17 Nov (2) - quality is worth the premium
Quality is worth paying a premium for and a company covered here has many of the attributes of an extremely good business. Others look more challenged, as you can discover here.
AdEPT: results underwhelm
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on AdEPT Technology
Chain gains | Another takeover | Big dividend
News covered here includes a promising update from a lowly valued engineering group, another equity raise…
As frustrating as ever
News from AIM covered here, include results from one of AIM’s more elderly companies and one…
More on Craneware
AI opportunities galore
News covered here includes updates from several software groups which look well-placed to be beneficiaries of…
Upgrades galore | Litigation bounce | Big ambitions
While Trump’s latest threats disturb stock markets, AIM companies covered here are trading well bringing upgrades…
More on dotDigital
Stonking Small Cap: expanded offering and well set to thrive
This brilliant little company has delivered consistent excellence over a number of years, yet it still has…
Double digit growth | Stonking Small Cap updates
Our coverage here includes a review of stunning results from a manufacturer of products for the…
More on Eagle Eye Solutions
Upgrades galore | Litigation bounce | Big ambitions
While Trump’s latest threats disturb stock markets, AIM companies covered here are trading well bringing upgrades…
AIM new arrival | Excellent update | Big warning
2024 was another difficult year for London’s junior stock market with plenty of departures and few…
More on IDOX
15% dividend yield | Soaring shares | Yet another takeover
Results and updates covered here brought a big sell-off in the share prices of two stocks,…
Horror show | No deal | Bonkers Bargain delights
News covered here included our assessment of results from a provider of software to the public…
More on Scapa Group
Scaparing!
This AIM struggler is getting acquired by a US listed company. While the acquisition price is…
Vaccine countdown update: 17 Nov (2) - quality is worth the premium
Quality is worth paying a premium for and a company covered here has many of the…
